These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35880111)

  • 1. Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood-Brain Barrier.
    Chen YP; Chou CM; Chang TY; Ting H; Dembélé J; Chu YT; Liu TP; Changou CA; Liu CW; Chen CT
    Front Chem; 2022; 10():931584. PubMed ID: 35880111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier.
    Chen ZA; Wu CH; Wu SH; Huang CY; Mou CY; Wei KC; Yen Y; Chien IT; Runa S; Chen YP; Chen P
    ACS Nano; 2024 May; 18(20):12716-12736. PubMed ID: 38718220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
    Mo J; He L; Ma B; Chen T
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
    Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
    Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-Triggered Charge-Reversal Mesoporous Silica Nanoparticles Stabilized by Chitosan Oligosaccharide/Carboxymethyl Chitosan Hybrids for Effective Intracellular Delivery of Doxorubicin.
    Cui L; Liu W; Liu H; Qin Q; Wu S; He S; Pang X; Zhu C; Shen P
    ACS Appl Bio Mater; 2019 May; 2(5):1907-1919. PubMed ID: 35030680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
    Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
    PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
    Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability.
    Wang Y; Sun Y; Wang J; Yang Y; Li Y; Yuan Y; Liu C
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17166-75. PubMed ID: 27314423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior doxorubicin cellular delivery effect established by optically active mesoporous silica nanoparticles.
    Wang L; Yu D; Li D; Li J
    Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38381319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Mesoporous Silica Nanoparticles through Statistical Design of Experiment and the Application for the Anticancer Drug.
    Kim MK; Ki DH; Na YG; Lee HS; Baek JS; Lee JY; Lee HK; Cho CW
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33572523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy.
    Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L
    Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
    He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
    Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Features for Mesoporous Silica Nanoparticles Encapsulated into Erythrocytes.
    Chen ZA; Wu SH; Chen P; Chen YP; Mou CY
    ACS Appl Mater Interfaces; 2019 Feb; 11(5):4790-4798. PubMed ID: 30624037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.